Exact Therapeutics Abstract on its Phase I ACTIVATE Study to be Presented at the 2021 ASCO Annual Meeting
Exact Therapeutics Abstract on its Phase I ACTIVATE Study to be Presented at the 2021 ASCO Annual Meeting News provided by Share this article Share this article OSLO, Norway and LONDON, May 20, 2021 /PRNewswire/ -- Exact Therapeutics AS (Euronext Growth: EXTX), a clinical stage precision medicine company utilizing Acoustic Cluster Therapy (ACT®) to harness the power of ultrasound in therapeutic amplification across multiple therapeutic areas and product classes, today announces that an abs...
City Of United Kingdom Udai Banerji Institute Of Cancer Research Company Acoustic Cluster Therapy Exact Therapeutics
Source: prnewswire.com